# A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1

> **NCT06191354** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Kun Sun** · enrollment: 12 (estimated)

## Conditions studied

- Spinal Muscular Atrophy 1

## Interventions

- **GENETIC:** SKG0201 Injection

## Key facts

- **NCT ID:** NCT06191354
- **Lead sponsor:** Kun Sun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-25
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06191354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06191354, "A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06191354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*